Thyroid & Anti-thyroid Drugs Flashcards
what are the thyroid hormones?
what hormones trigger their release?
T3 and T4
hypothalmic-pituitary-thyroid axis:
- TRH (hypothalamus) –> TSH (anterior pituitary) –> T3, T4 (follicular cells)
discuss the regulators of the hypothalamic-pituitary-thyroid axis?
inhibition:
TRH & TSH both by T3,T4 (feedback)
TRH: by chronic stress
TSH: by
- somatostatin (also inhibits somatotrophes)
- dopamine (also inhibits lactotrophes)
- glucocorticoids
whta inhibits release of TRH from hypothalamus?
- T3/T4 (negative feedback)
- chronic stress
what are low, normal and high TSH levels
define hyperthyroidism / thyrotoxicosis
what are the major causes of hyperthryoidism?
= hypermetabolic state due to excess circulating T3, T4
major causes
- primary
- Grave’s (thyroid hyperplasia)
-
thyroiditis - inflammation/fibrosis damages thyroid & leads to excess TH release
- granulomatous, subacute lympocytic
- thyroid nodules / multdinodular goiter
- excess consumption of: 1. iodine or 2. TH supplements
Graves is most common in what population?
women 20-40 yrs
what are the major manifestations of hyperthyroidism / thyrotoxicity?
= hypermetabolic state
- too hot (heat intolerant)
- weight loss (increased metabolic rate)
- inc GI activity –> diarrhea
- rapid DTRs
- tachycardia / tachyarrythmias –>. HF
hyperthyoidism is managed generally by what drug classes?
(list the drugs in each class)
- antithyroid drugs:
- thioamides: methimazol, propylthiouracil (PTU)
- iodies (KI)
- radioactive iodine (131I)
- thyroidectomy
thioamides
- incudes what drugs?
- have what MOA?
- have what clinical uses?
- what general AEs?
methimazole, propylthiouracil (PTU)
- MOA: both inhibit TH synthesis by inhibition of thyroperoxidase (no thyroglobulin iodination) PTU also inhibits T4–>T3
- clinical use: hyperthyroidism
- AEs: 1. hepatotoxicity, 2. dangerous in pregnancy
methimazole
- what kind of drug?
- what MOA?
- clinical uses?
- PK - onset / potency / half life
- AEs/CIs?
- is a thioamide (antithyroid drug)
- MOA: inhibits TH synthesis by i_nhibiting thyroperoxidase_
- clinical uses: first line drug for hyperthyroidism
- PK:
- onset - rapid
- highly potent (> PTU)
- t1/2 = 6 hrs (> PTU)
- AE:
- hepatoxic: hepatic failure / hepatitis / jaundice (< PTU)
- teratogenic (> PTU)
- agranulocytosis
- common - GI/rash/fever
- CI: 1st trimester of pregnancy
propylthiouracil (PTU)
- what kind of drug?
- what MOA?
- clinical uses?
- PK - onset / potency / half life
- thioamine (antithyroid drug)
- MOA:
- inhibits TH synthesis by inhibiting thyroperoxidase
- inhibits T4–>T3 synthesis by inhibiting D1 5’-diodinase
- clinical:
- hyperthyroidism in 1st trimester of pregnancy
- thyroid storm
- if pt has AEs to methimazole
- PK
- onset - slow
- potency - low (< PTU)
- t1/2 = 1.5 ( < PTU)
- AEs:
- hepatoxic: hepatic failure / hepatitis / jaundice (> methimazole)
- teratogenic (< PTU)
- agranulocytosis
- common - GI/rash/fever
when is PTU preferred over methimazole?
- for pt in 1st trimester of pregnancy
- for a “thyroid storm” - inhibits T3/T4 conversion
how does propylthiouracil (PTU) differ from methiomazole pharmokinetically
PTU has
- < potency
- < half life
- slower onset of action (3-4 wks)
- more toxic - i.e., hepatotoxic
potassium iodide (KI)
- what kind of drug?
- what MOA?
- what cinical uses?
- AEs?
- CIs?
- antithyroid drug
- MOA:
- 150 mg (recommended dose): of proteolysis
- > 6 mg: inhibits t_hyroperoxidase enzyme_
- clinical uses:
- decrease size/vascularity of thyroid gland prior to surgery
- inhibit uptake of radioactive iodine after exposure - likely following a nuclear accident
- AEs:
- GI: unpleasant taste / salivary gland inflammation / gastritis
- immune: anaphyolaxis / angioedema / thormbocytopenia
- skin lesion
- C/I:
- within 3 weeks prior to 131iodine radioation therapy
in what form is KI given?
lugol’s solution
anion inhibitors
- include what drugs?
- are what kind of drugs?
- have what MOA?
- have what clinical uses?
ate- perchlorate, pertechnetate, thiocynate
- antithyroid drugs
- MOA: competitive inhibition of I- uptake by Na/I symptorter on follicular cell
- clinical use: tx of hyperthyroidism due to excess iodine consumption
- (ex - amiodarone-indued)
- AE:
- aplastic anemia
perchlorate
- what kind of drug
- MOA
- clinical uses
- AE
- antithyroid drugs
- MOA: competitive inhibition of I- uptake by Na/I symptorter (NIS) on follicular cell
- clinical use: tx of hyperthyroidism due to excess iodine consumption
- (ex - amiodarone)
- AE:
- aplastic anemia